Get informed when a big investor buys or sells
+ Follow11.34%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) currently reports a ROE of 11.34%. That is below the sector sector average of 11.64%. Use the charts on this page to explore Beijing Tong Ren Tang Chinese Medicine Company Limited's ROE history and peer comparisons.
Beijing Tong Ren Tang Chinese Medicine Company Limited's ROE of 11.34% is lower than the its sector sector average of 11.64%. That is roughly 2.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Beijing Tong Ren Tang Chinese Medicine Company Limited's current 11.34% should be judged against industry norms (sector average: 11.64%) and against BJTRF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 11.34%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.64%. From there, open related valuation or income-statement pages for Beijing Tong Ren Tang Chinese Medicine Company Limited, and consider following BJTRF for alerts when major investors trade the stock.